F-16
Neuraxial Block Record
دليل السياسات والإجراءات في التخدير — Section M

Form F-16 Preview

Neuraxial Block Record (2-Page Table Format)

NEURAXIAL BLOCK RECORD (Spinal / Epidural / CSE)
Hospital: ________________________ | Dept of Anesthesia Form Code: F-16 | Version: ___ | Effective: ___ | PAGE 1 of 2
B) PATIENT IDENTIFIERS
Name: _______________________________ MRN: _______________ DOB/Age: _________ Wt (kg): _____
Allergies: _______________________________________
(Latex: Yes No | Chlorhexidine: Yes No)
Location: OR   L&D   NORA   Block Area
Date/Time: _______________________
C) INDICATION Surgical anesthesia    Labor analgesia    Postop analgesia    Other: ______________
D) PRE-BLOCK SAFETY
Consent obtained
ASA Class: ___
Baseline vitals: BP _______ / HR _______ / SpO₂ _______
Anticoag/antiplatelet reviewed & acceptable: Yes No N/A
   Last dose/time: ________________________
Labs if indicated: Platelets _______ INR _______ Other: _______
Infection at insertion site: No    Yes (explain): _________________________________
Stop/concerns communicated: Yes No
E) TECHNIQUE SELECTION F) ASEPSIS
Spinal    Epidural    CSE

Position: Sitting    Lateral
Approach: Midline    Paramedian
Level(s) attempted: _______________    # Attempts: ___
Skin prep:
CHG/Alcohol    Povidone-Iodine    Other: _______

Precautions:
Sterile gloves    Mask    Sterile drape
Sterile gown (if required by policy)
G) PROCEDURE DETAILS
Needle type/gauge: ___________________________________
For SPINAL
CSF obtained: Yes    No

Drug Conc Dose Adjuvant
For EPIDURAL / CSE
LOR medium: Saline    Air   |   Catheter depth at skin: _____ cm
Aspiration: Negative    Positive (action): _________________
Test dose used: Yes    No   |   Details: ________________
Initial Bolus Drug Conc Vol Time
H) MONITORING & SEDATION DURING PLACEMENT Monitoring: NIBP   SpO₂   ECG
Sedation: None   Yes (drug/dose): ________________________________
I) BLOCK ASSESSMENT & EVENTS
Sensory level: ____________________

Motor block: ______________________
Complications:
Hypotension    Bradycardia    High block    PDPH/dural puncture
Paresthesia    Vascular puncture    N/V    Other: ___________

Actions taken + response: _____________________________________________
J) IMMEDIATE POST-BLOCK PLAN K) SIGNATURES
Fall precautions: Yes    No
Monitoring frequency: ____________________________
Postop analgesia plan: ____________________________
Handover notes to PACU/ward:
__________________________________________________
Performed by:
Name: ___________________________________________
Sign: __________________________ Time: ____________

Supervisor (if required):
Name: ___________________________________________
Sign: __________________________ Time: ____________
NEURAXIAL BLOCK RECORD (Spinal / Epidural / CSE)
Patient Name: _________________________ | MRN: _______________ Form Code: F-16 | PAGE 2 of 2
L) CATHETER / INFUSION ORDER (if applicable)
Solution (drug + conc): ____________________________________________________________________________
Basal rate: _______ mL/hr      Bolus: _______ mL

Lockout: _______ min          Max/hr: _______ mL
Start date/time: ________________________

Line labeling confirmed: Yes    No
Pump settings verified (double-check if policy): Yes    No
M) NEUROLOGIC SAFETY & ESCALATION N) ANTICOAG PLAN / RESTART
Nursing neuro checks frequency: __________________

RED FLAGS—Escalate immediately if:
New/worsening motor weakness
Severe back pain
Bowel/bladder dysfunction
Progressive numbness beyond expected distribution
Fever or catheter site discharge
Restart plan (per local protocol):
________________________________________________
________________________________________________
________________________________________________

Removal plan reference:
“Use F-16 Catheter Removal Checklist”    Noted
O) NOTES / COMMENTS





P) PAGE 2 SIGNATURES
APS / Regional Reviewer:

Name: _________________________________      Signature: ___________________________      Date/Time: ________________
Standards alignment: CBAHI perioperative safety; neuraxial safety + documentation; anticoag safety per adopted guideline.